Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2008
12/31/2008WO2009002193A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
12/31/2008WO2009001940A1 Cancer remedy containing antibody against peptide encoded by exon-17 of periostin
12/31/2008WO2009001915A1 Substituted imidazole compound and use thereof
12/31/2008WO2009001867A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
12/31/2008WO2009001840A1 Anti-prominin-1 antibody having adcc activity or cdc activity
12/31/2008WO2009001562A1 Compositions and methods of treating cancer
12/31/2008WO2009001219A2 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
12/31/2008WO2009001209A1 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
12/31/2008WO2009001046A2 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use
12/31/2008WO2009001021A1 Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases
12/31/2008WO2009000971A2 Peptide gacfsiahecga for targeting mtl-mmp
12/31/2008WO2009000937A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
12/31/2008WO2009000832A2 Chemical compounds
12/31/2008WO2009000785A2 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
12/31/2008WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
12/31/2008WO2009000504A2 Injectable formulation for photodynamic therapy
12/31/2008WO2009000489A1 Benzimidazole amido derivatives as kinase inhibitors
12/31/2008WO2009000297A1 Tpp ii inhibitors for use in combination with chemotherapy for the treatment of cancer
12/31/2008WO2009000137A1 A inhibiting agent for inhibition of angiogenesis, a method for preparing the agnet, a method for modifying the agent and its use for manufacturing a medicament for treating tumor
12/31/2008WO2009000023A1 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors
12/31/2008WO2008141044A3 Cysteine engineered anti-muc16 antibodies and antibody drug conjugates
12/31/2008WO2008140782A3 Compounds for enzyme inhibition
12/31/2008WO2008140507A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
12/31/2008WO2008136705A3 Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof
12/31/2008WO2008132568A3 Fusion proteins binding to growth factors
12/31/2008WO2008132541A3 Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
12/31/2008WO2008132138A9 Derivatives of 4,6-disubstituted aminopyrimidines
12/31/2008WO2008132138A8 Derivatives of 4,6-disubstituted aminopyrimidines
12/31/2008WO2008131354A3 Phytoestrogens as regulators of hedgehog signaling and methods of their use in cancer treatment
12/31/2008WO2008129288A3 Disulfonamides useful in the treatment of inflammation
12/31/2008WO2008128072A3 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
12/31/2008WO2008122767A3 2, 6, 9-substituted purine derivatives having anti proliferative properties
12/31/2008WO2008112290A3 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
12/31/2008WO2008109493B1 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
12/31/2008WO2008109493A4 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
12/31/2008WO2008108941A3 Integrated photoactive peptides and uses thereof
12/31/2008WO2008103905A3 Antibodies that specifically bind irta and methods of use
12/31/2008WO2008089388A3 Treatment of cancers having resistance to chemotherapeutic agents
12/31/2008WO2008073294A3 Inhibition of angiogenesis and tumor growth by inhibitors of beta ii or delta protein kinase c
12/31/2008WO2008023278A8 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain
12/31/2008WO2008022060A3 Imidazo-pyridine derivatives for modulating protein kinase activity
12/31/2008WO2008011406A3 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
12/31/2008WO2007131689A3 Pharmaceutical combinations comprising a mtor inhibitor and a raf kinase inhibitor
12/31/2008EP2009443A1 Diagnostic agent and therapeutic agent for pancreatic cancer
12/31/2008EP2009119A1 Compositions for treating cancer using viruses
12/31/2008EP2009028A1 Combination of a conventional anti-cancer treatment with anti-CD44 antibody administration for treating solid tumors
12/31/2008EP2009027A1 Anti-CD40 monoclonal antibody
12/31/2008EP2009019A1 P53 binding T cell receptor molecules and uses thereof
12/31/2008EP2009008A1 Imatinib base, and imatinib mesylate and processes for preparation thereof
12/31/2008EP2008665A1 Injectable formulation for photodynamic therapy
12/31/2008EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
12/31/2008EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides
12/31/2008EP2008652A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
12/31/2008EP2008649A1 Spill resistant pharmaceutical compositions
12/31/2008EP2007811A2 Targeted binding agents directed to upar and uses thereof
12/31/2008EP2007809A1 Glycosylated antibodies
12/31/2008EP2007777A1 Calixarene derivatives as anticancer agent
12/31/2008EP2007774A1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors
12/31/2008EP2007773A1 Thiazolyl dihydro-indazoles
12/31/2008EP2007769A1 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
12/31/2008EP2007767A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors
12/31/2008EP2007757A2 Thiophene-carboxamides useful as inhibitors of protein kinases
12/31/2008EP2007736A1 Substituted quinazolines with anti-cancer activity
12/31/2008EP2007733A1 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
12/31/2008EP2007732A2 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/31/2008EP2007715A2 Tetracycline compounds and methods of treatment
12/31/2008EP2007714A2 Orally bioavailable caffeic acid related anticancer drugs
12/31/2008EP2007711A1 5-aminolevulinic acid salts and their use
12/31/2008EP2007428A2 Method for using boc/cdo to modulate hedgehog signaling
12/31/2008EP2007423A2 Ctla4 antibody combination therapy
12/31/2008EP2007418A1 Reversibly inhibited antibodies for immune cell stimulation
12/31/2008EP2007410A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides
12/31/2008EP2007400A1 New medicines for treatments against retroviruses
12/31/2008EP2007391A2 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
12/31/2008EP2007386A2 Camptothecin-analog with a novel, flipped lactone-stable, e-ring and methods for making and using same
12/31/2008EP2007383A2 Inhibitors of protein prenyltransferases
12/31/2008EP2007382A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
12/31/2008EP2007380A2 Use of a kinase inhibitor for the treatment of particular resistant tumors
12/31/2008EP2007370A1 Novel composition for tumor growth control
12/31/2008EP1928469A4 Fulvestrant formulation
12/31/2008EP1896489B1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
12/31/2008EP1855665B1 Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (vhl) disease
12/31/2008EP1851198B1 Substituted pyrroles, compositions containing same, method for making same and use thereof
12/31/2008EP1838283B1 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
12/31/2008EP1732926B1 Mitotic kinesin inhibitors
12/31/2008EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors
12/31/2008EP1678193B1 Hepatocellular carcinoma specific promoter and uses thereof
12/31/2008EP1648905B1 Thienopyridine and furopyridine kinase inhibitors
12/31/2008EP1535926B1 Carbacyclic phosphatidic acid derivative
12/31/2008EP1534823A4 The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
12/31/2008EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/31/2008EP1424942B1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy
12/31/2008EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
12/31/2008EP1406867B1 Thiolalkyl benzoic acid derivatives
12/31/2008EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
12/31/2008EP1309587B1 Cinnoline compounds
12/31/2008EP1272527B1 Preparation of antibodies having adcc via cd16, such as anti-rhesus d monoclonal antibodies
12/31/2008EP1268761B1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/31/2008EP1266009B1 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF
12/31/2008EP1255850B1 Amplification of cyp24 and uses thereof
1 ... 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 ... 2211